New study pits pill against laser for baby birthmarks
NCT ID NCT07560332
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This study compared two treatments for infantile hemangioma, a common birthmark: oral propranolol (a pill) and a laser-assisted topical timolol (a drop applied to the skin after laser treatment). The trial included 30 children aged 1 month to 12 years. The goal was to see which approach works better and is safer for shrinking these growths.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFANTILE HEMANGIOMA (IH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cairo University
Cairo, 11562, Egypt
Conditions
Explore the condition pages connected to this study.